Xcout Intel
Psyence Biomedical Ltd.
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.
Subscribe to see Psyence Biomedical Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Psyence Biomedical Ltd. at a glance
Psyence Biomedical Ltd. is a biotech company headquartered in Toronto, Canada. It is publicly listed (PBM) with a market capitalisation of $68,659. Xcout tracks 12 named people at Psyence Biomedical Ltd., including Neil Maresky (Chief Executive Officer).
Psyence Biomedical Ltd. leadership
- Neil MareskyChief Executive Officer
- Warwick Ron Corden-LloydCFO & Director
- Jody AufrichtigCo-Founder, Executive Chairman & Chief Executive Officer
- Neil MareskyGlobal Head of Clinical Development
- Jody AufrichtigExecutive Officer
- Taryn VosGeneral Counsel
6 more named people on record for Psyence Biomedical Ltd., with roles, board committees and tenure — see the full roster →
Get Psyence Biomedical Ltd.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Psyence Biomedical Ltd. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access